This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
S&P 500 Posts 5th Straight Weekly Gain: 5 Great Picks
by Nalak Das
U.S. corporates have so far posted robust results for second-quarter 2018, maintaining the terrific earnings momentum which has begun since the first-quarter 2018.
5 Value Stocks Hotter than Apple in 2018
by Tracey Ryniec
It's the unicorn of investing: value stocks that are breaking out. Find out what they are in this week's podcast.
Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM
by Zacks Equity Research
Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM
Strong Earnings in Surprising Sectors: Zacks August Strategy
by John Blank
The simplest way to summarize the aggregated Q2 company data is that both earnings growth and revenue growth have been strong, as expected.
5 Cheap PEG Stocks Suitable for GARP Investors
by Zacks Equity Research
Although PEG is categorized under value investing, this strategy follows the principles of both growth and value investing.
Buy 5 Low-Beta Stocks as US-China Trade Tensions Escalate
by Nalak Das
Trump administration is deeply concerned about China's drive to unseat the United States as the primary developer and supplier of products in the fields of high-tech digital industries.
New Strong Buy Stocks for August 1st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Acadia Healthcare (ACHC) Posts In-Line Q2 Earnings, Cuts View
by Zacks Equity Research
Acadia Healthcare (ACHC)'s second-quarter earnings grow on the back of extra beds procured by units facilities. However, the company trims its full-year view.
Community Health (CYH) Incurs Lower Loss Than Expected in Q2
by Zacks Equity Research
Community Health's (CYH) Q2 results suffer loss from decline in admissions.
Company News For Jul 26, 2018
by Zacks Equity Research
Companies In The News are: GM,KO,UPS,HCA
HCA Healthcare (HCA) Beats on Q2 Earnings, Revises Guidance
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter earnings grow on the back of solid revenues and increased admissions.
HCA Healthcare (HCA) Beats on Q2 Earnings, Revenues
by Zacks Equity Research
HCA Healthcare's (HCA) Q2 results reflect improved revenues as well as increase in admission
HCA, UHS to Report Q2 Earnings on Jul 25: Key Predictions
by Zacks Equity Research
Medical stocks are expected to show lower profitability in Q2 earnings.
What's in the Cards for HCA Healthcare (HCA) in Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q2 results are likely to be aided by a strong top line, riding on higher admissions, partially offset by increasing costs.
Why Is HCA Healthcare (HCA) Up 7.4% Since Its Last Earnings Report?
by Zacks Equity Research
HCA Healthcare (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare (HCA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
HCA Healthcare (HCA) Q1 earnings reflect improved revenues, increase in admissions and favorable impact of share buyback.
Should Value Investors Pick HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Is HCA Healthcare (HCA) a great pick from the value investor's perspective right now? Read on to know more.
The Zacks Analyst Blog Highlights: Express Scripts, Nissan Motor and HCA Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Express Scripts, Nissan Motor and HCA Holdings
5 Growth Stocks in MedTech Set to Scale Higher in 2018
by Zacks Equity Research
The U.S. MedTech markets have been riding high with merger and acquisitions in focus.
Here Comes the CPI: Global Week Ahead
by John Blank
U.S. consumer price data for February will be closely watched on Tuesday.
Zacks.com featured highlights include: ePlus, HCA, US Foods, Best Buy and Ruth???s
by Zacks Equity Research
Zacks.com featured highlights include: ePlus, HCA, US Foods, Best Buy and Ruth???s
Invest in These 5 Stocks Powered by Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Tenet Healthcare (THC) Surges: Stock Moves 8.9% Higher
by Zacks Equity Research
Shares of Tenet Healthcare (THC) rose 9% yesterday after the company reported better-than-expected fourth-quarter results.
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Forget Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We have figured out a proven strategy that says lucrative returns can also be earned from less-risky stocks if some other parameters are considered.